Publications by authors named "Will Irving"

Claim this Profile
T
The role of the clinical virologist in pandemic responses.
Jangu E Banatvala, Peter Muir, Will Irving, Emma Meader, Sandeep Ramalingam

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, Karl Heinz Weiss, Will Irving

Hepatol Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical virology in the pandemic response-a missed opportunity.
Jangu Banatvala, Peter Muir, Will Irving, Mark Zuckerman

BMJ· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of virus subtype and host genotype on large-scale RNA structure formation in the genome of hepatitis C virus.
Peter Simmonds, Lize Cuypers, Will L Irving, John McLauchlan, Graham S Cooke

RNA· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
Hamish Innes, Stephan Buch, Sharon Hutchinson, Indra Neil Guha, Joanne R Morling, Will Irving

Gastroenterology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid roll out of SARS-CoV-2 antibody testing-a concern.
Monique Andersson, Nicola Low, Neil French, Trisha Greenhalgh, Katie Jeffery, Will Irving

BMJ· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reported 'clear cut time association between interferon-free treatment and HCC' is anything but clear cut.
Hamish A Innes, Scott A McDonald, Stephen T Barclay, Will L Irving, Peter C Hayes

J Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
Kirsty Roberts, John Macleod, Chris Metcalfe, Will Hollingworth, Jack Williams, Will Irving

BMJ· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of direct-acting antivirals: UK real-world data from a well-characterised predominantly cirrhotic HCV cohort.
Lucia Macken, William Gelson, Matthew Priest, George Abouda, Stephen Barclay, Will Irving

J Med Virol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis.
Alexis Llewellyn, Mark Simmonds, Will L Irving, Ginny Brunton, Amanda J Sowden

Hepatol Med Policy· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.
Keyur Patel, Katja S Remlinger, Terence G Walker, Peter Leitner, Joseph E Lucas, Will Irving

Clin Gastroenterol Hepatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection.
Sam Lattimore, Will Irving, Sarah Collins, Celia Penman, Mary Ramsay

Hepatology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of hepatitis C treatment response: what's new?
Louise Berry, Will Irving

Expert Rev Anti Infect Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parvovirus 4 infection and clinical outcome in high-risk populations.
Ruth Simmons, Colin Sharp, C Patrick McClure, Janine Rohrbach, Helen Kovari, Will Irving

J Infect Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General practice characteristics associated with rates of testing and detection of hepatitis C: cross-sectional study in Nottingham and Derbyshire.
Carol Coupland, Julia Hippisley-Cox, Sherie Smith, Will Irving, Mike Pringle

Br J Gen Pract· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis